7:17 PM
 | 
Dec 15, 2014
 |  BC Extra  |  Financial News

Annexon raises $34M in series A-1

Annexon Bioscience raised $34 million in a series A-1 round led by Novartis Venture Fund along with Satter Investment Management and Clarus Ventures. All were new investors. CEO Doug Love told BioCentury the round is "committed,"...

Read the full 160 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >